Eloxx Pharmaceuticals, Inc. of ARLINGTON, MA filed a DEFA14A with the SEC on 2023-04-28. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | FORM DEFA14A |
| 2 | GRAPHIC | ny20007761x2_nc01.jpg |
| 3 | GRAPHIC | ny20007761x2_nc02.jpg |
Showing 12 of 53 filings.
| Filed | Form |
|---|---|
| 2026-05-08 | DEF 14C |
| 2026-04-28 | PRE 14C |
| 2023-04-28 | DEFA14A |
| 2023-04-28 | DEF 14A |
| 2022-10-31 | DEF 14A |
| 2022-10-17 | PRE 14A |
| 2022-04-29 | DEFA14A |
| 2022-04-29 | DEF 14A |
| 2021-04-01 | DEFA14A |
| 2021-04-01 | DEF 14A |
| 2020-04-01 | DEFA14A |
| 2020-04-01 | DEF 14A |